line_item,period,value,symbol
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,ENFUSE.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.203249,ENFUSE.NS
Normalized EBITDA,2024-03-31 00:00:00,88730000.0,ENFUSE.NS
Total Unusual Items,2024-03-31 00:00:00,,ENFUSE.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,,ENFUSE.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,53608000.0,ENFUSE.NS
Reconciled Depreciation,2024-03-31 00:00:00,14475000.0,ENFUSE.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,210748000.0,ENFUSE.NS
EBITDA,2024-03-31 00:00:00,88730000.0,ENFUSE.NS
EBIT,2024-03-31 00:00:00,74255000.0,ENFUSE.NS
Net Interest Income,2024-03-31 00:00:00,-8213000.0,ENFUSE.NS
Interest Expense,2024-03-31 00:00:00,6973000.0,ENFUSE.NS
Interest Income,2024-03-31 00:00:00,1366000.0,ENFUSE.NS
Normalized Income,2024-03-31 00:00:00,53608000.0,ENFUSE.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,53608000.0,ENFUSE.NS
Total Expenses,2024-03-31 00:00:00,321439000.0,ENFUSE.NS
Rent Expense Supplemental,2024-03-31 00:00:00,19019000.0,ENFUSE.NS
Diluted Average Shares,2024-03-31 00:00:00,,ENFUSE.NS
Basic Average Shares,2024-03-31 00:00:00,,ENFUSE.NS
Diluted EPS,2024-03-31 00:00:00,,ENFUSE.NS
Basic EPS,2024-03-31 00:00:00,,ENFUSE.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,53608000.0,ENFUSE.NS
Net Income Common Stockholders,2024-03-31 00:00:00,53608000.0,ENFUSE.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,ENFUSE.NS
Net Income,2024-03-31 00:00:00,53608000.0,ENFUSE.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,53607000.0,ENFUSE.NS
Net Income Continuous Operations,2024-03-31 00:00:00,53607000.0,ENFUSE.NS
Tax Provision,2024-03-31 00:00:00,13675000.0,ENFUSE.NS
Pretax Income,2024-03-31 00:00:00,67282000.0,ENFUSE.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,,ENFUSE.NS
Special Income Charges,2024-03-31 00:00:00,,ENFUSE.NS
Write Off,2024-03-31 00:00:00,,ENFUSE.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-8213000.0,ENFUSE.NS
Total Other Finance Cost,2024-03-31 00:00:00,2606000.0,ENFUSE.NS
Interest Expense Non Operating,2024-03-31 00:00:00,6973000.0,ENFUSE.NS
Interest Income Non Operating,2024-03-31 00:00:00,1366000.0,ENFUSE.NS
Operating Income,2024-03-31 00:00:00,77083000.0,ENFUSE.NS
Operating Expense,2024-03-31 00:00:00,110691000.0,ENFUSE.NS
Other Operating Expenses,2024-03-31 00:00:00,37003000.0,ENFUSE.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,14475000.0,ENFUSE.NS
Amortization,2024-03-31 00:00:00,,ENFUSE.NS
Depreciation Income Statement,2024-03-31 00:00:00,14475000.0,ENFUSE.NS
Selling General And Administration,2024-03-31 00:00:00,19238000.0,ENFUSE.NS
Selling And Marketing Expense,2024-03-31 00:00:00,4830000.0,ENFUSE.NS
General And Administrative Expense,2024-03-31 00:00:00,14408000.0,ENFUSE.NS
Rent And Landing Fees,2024-03-31 00:00:00,19019000.0,ENFUSE.NS
Gross Profit,2024-03-31 00:00:00,187774000.0,ENFUSE.NS
Cost Of Revenue,2024-03-31 00:00:00,210748000.0,ENFUSE.NS
Total Revenue,2024-03-31 00:00:00,398522000.0,ENFUSE.NS
Operating Revenue,2024-03-31 00:00:00,398522000.0,ENFUSE.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,0.0,ENFUSE.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.21108,ENFUSE.NS
Normalized EBITDA,2023-03-31 00:00:00,50408000.0,ENFUSE.NS
Total Unusual Items,2023-03-31 00:00:00,-168000.0,ENFUSE.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,-168000.0,ENFUSE.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,31927000.0,ENFUSE.NS
Reconciled Depreciation,2023-03-31 00:00:00,8300000.0,ENFUSE.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,149816000.0,ENFUSE.NS
EBITDA,2023-03-31 00:00:00,50408000.0,ENFUSE.NS
EBIT,2023-03-31 00:00:00,42108000.0,ENFUSE.NS
Net Interest Income,2023-03-31 00:00:00,-1585000.0,ENFUSE.NS
Interest Expense,2023-03-31 00:00:00,1640000.0,ENFUSE.NS
Interest Income,2023-03-31 00:00:00,55000.0,ENFUSE.NS
Normalized Income,2023-03-31 00:00:00,31927000.0,ENFUSE.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,31927000.0,ENFUSE.NS
Total Expenses,2023-03-31 00:00:00,218502000.0,ENFUSE.NS
Rent Expense Supplemental,2023-03-31 00:00:00,7769000.0,ENFUSE.NS
Diluted Average Shares,2023-03-31 00:00:00,8847600.0,ENFUSE.NS
Basic Average Shares,2023-03-31 00:00:00,8847600.0,ENFUSE.NS
Diluted EPS,2023-03-31 00:00:00,3.608549,ENFUSE.NS
Basic EPS,2023-03-31 00:00:00,3.608549,ENFUSE.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,31927000.0,ENFUSE.NS
Net Income Common Stockholders,2023-03-31 00:00:00,31927000.0,ENFUSE.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,ENFUSE.NS
Net Income,2023-03-31 00:00:00,31927000.0,ENFUSE.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,31926000.0,ENFUSE.NS
Net Income Continuous Operations,2023-03-31 00:00:00,31926000.0,ENFUSE.NS
Tax Provision,2023-03-31 00:00:00,8542000.0,ENFUSE.NS
Pretax Income,2023-03-31 00:00:00,40468000.0,ENFUSE.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,1000.0,ENFUSE.NS
Special Income Charges,2023-03-31 00:00:00,-168000.0,ENFUSE.NS
Write Off,2023-03-31 00:00:00,168000.0,ENFUSE.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-1585000.0,ENFUSE.NS
Total Other Finance Cost,2023-03-31 00:00:00,469000.0,ENFUSE.NS
Interest Expense Non Operating,2023-03-31 00:00:00,1640000.0,ENFUSE.NS
Interest Income Non Operating,2023-03-31 00:00:00,55000.0,ENFUSE.NS
Operating Income,2023-03-31 00:00:00,42483000.0,ENFUSE.NS
Operating Expense,2023-03-31 00:00:00,68686000.0,ENFUSE.NS
Other Operating Expenses,2023-03-31 00:00:00,21757000.0,ENFUSE.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,8300000.0,ENFUSE.NS
Amortization,2023-03-31 00:00:00,1850000.0,ENFUSE.NS
Depreciation Income Statement,2023-03-31 00:00:00,8300000.0,ENFUSE.NS
Selling General And Administration,2023-03-31 00:00:00,15360000.0,ENFUSE.NS
Selling And Marketing Expense,2023-03-31 00:00:00,3180000.0,ENFUSE.NS
General And Administrative Expense,2023-03-31 00:00:00,12180000.0,ENFUSE.NS
Rent And Landing Fees,2023-03-31 00:00:00,7769000.0,ENFUSE.NS
Gross Profit,2023-03-31 00:00:00,111169000.0,ENFUSE.NS
Cost Of Revenue,2023-03-31 00:00:00,149816000.0,ENFUSE.NS
Total Revenue,2023-03-31 00:00:00,260985000.0,ENFUSE.NS
Operating Revenue,2023-03-31 00:00:00,260985000.0,ENFUSE.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,0.0,ENFUSE.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.263148,ENFUSE.NS
Normalized EBITDA,2022-03-31 00:00:00,32552000.0,ENFUSE.NS
Total Unusual Items,2022-03-31 00:00:00,0.0,ENFUSE.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,0.0,ENFUSE.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,19811000.0,ENFUSE.NS
Reconciled Depreciation,2022-03-31 00:00:00,5051000.0,ENFUSE.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,166778000.0,ENFUSE.NS
EBITDA,2022-03-31 00:00:00,32552000.0,ENFUSE.NS
EBIT,2022-03-31 00:00:00,27501000.0,ENFUSE.NS
Net Interest Income,2022-03-31 00:00:00,-612000.0,ENFUSE.NS
Interest Expense,2022-03-31 00:00:00,615000.0,ENFUSE.NS
Interest Income,2022-03-31 00:00:00,48000.0,ENFUSE.NS
Normalized Income,2022-03-31 00:00:00,19811000.0,ENFUSE.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,19811000.0,ENFUSE.NS
Total Expenses,2022-03-31 00:00:00,228092000.0,ENFUSE.NS
Rent Expense Supplemental,2022-03-31 00:00:00,4761000.0,ENFUSE.NS
Diluted Average Shares,2022-03-31 00:00:00,8847600.0,ENFUSE.NS
Basic Average Shares,2022-03-31 00:00:00,8847600.0,ENFUSE.NS
Diluted EPS,2022-03-31 00:00:00,2.239138,ENFUSE.NS
Basic EPS,2022-03-31 00:00:00,2.239138,ENFUSE.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,19811000.0,ENFUSE.NS
Net Income Common Stockholders,2022-03-31 00:00:00,19811000.0,ENFUSE.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,ENFUSE.NS
Net Income,2022-03-31 00:00:00,19811000.0,ENFUSE.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,19811000.0,ENFUSE.NS
Net Income Continuous Operations,2022-03-31 00:00:00,19811000.0,ENFUSE.NS
Tax Provision,2022-03-31 00:00:00,7075000.0,ENFUSE.NS
Pretax Income,2022-03-31 00:00:00,26886000.0,ENFUSE.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,204000.0,ENFUSE.NS
Special Income Charges,2022-03-31 00:00:00,0.0,ENFUSE.NS
Write Off,2022-03-31 00:00:00,0.0,ENFUSE.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-612000.0,ENFUSE.NS
Total Other Finance Cost,2022-03-31 00:00:00,45000.0,ENFUSE.NS
Interest Expense Non Operating,2022-03-31 00:00:00,615000.0,ENFUSE.NS
Interest Income Non Operating,2022-03-31 00:00:00,48000.0,ENFUSE.NS
Operating Income,2022-03-31 00:00:00,27320000.0,ENFUSE.NS
Operating Expense,2022-03-31 00:00:00,61314000.0,ENFUSE.NS
Other Operating Expenses,2022-03-31 00:00:00,27360000.0,ENFUSE.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,5051000.0,ENFUSE.NS
Amortization,2022-03-31 00:00:00,875000.0,ENFUSE.NS
Depreciation Income Statement,2022-03-31 00:00:00,4176000.0,ENFUSE.NS
Selling General And Administration,2022-03-31 00:00:00,21339000.0,ENFUSE.NS
Selling And Marketing Expense,2022-03-31 00:00:00,1763000.0,ENFUSE.NS
General And Administrative Expense,2022-03-31 00:00:00,19576000.0,ENFUSE.NS
Rent And Landing Fees,2022-03-31 00:00:00,4761000.0,ENFUSE.NS
Gross Profit,2022-03-31 00:00:00,88634000.0,ENFUSE.NS
Cost Of Revenue,2022-03-31 00:00:00,166778000.0,ENFUSE.NS
Total Revenue,2022-03-31 00:00:00,255412000.0,ENFUSE.NS
Operating Revenue,2022-03-31 00:00:00,255412000.0,ENFUSE.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,0.0,ENFUSE.NS
Tax Rate For Calcs,2021-03-31 00:00:00,0.255068,ENFUSE.NS
Normalized EBITDA,2021-03-31 00:00:00,22154000.0,ENFUSE.NS
Total Unusual Items,2021-03-31 00:00:00,0.0,ENFUSE.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,0.0,ENFUSE.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,15543000.0,ENFUSE.NS
Reconciled Depreciation,2021-03-31 00:00:00,1289000.0,ENFUSE.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,87331000.0,ENFUSE.NS
EBITDA,2021-03-31 00:00:00,22154000.0,ENFUSE.NS
EBIT,2021-03-31 00:00:00,20865000.0,ENFUSE.NS
Net Interest Income,2021-03-31 00:00:00,-16000.0,ENFUSE.NS
Interest Expense,2021-03-31 00:00:00,0.0,ENFUSE.NS
Interest Income,2021-03-31 00:00:00,0.0,ENFUSE.NS
Normalized Income,2021-03-31 00:00:00,15543000.0,ENFUSE.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,15543000.0,ENFUSE.NS
Total Expenses,2021-03-31 00:00:00,151145000.0,ENFUSE.NS
Rent Expense Supplemental,2021-03-31 00:00:00,2582000.0,ENFUSE.NS
Diluted Average Shares,2021-03-31 00:00:00,8847600.0,ENFUSE.NS
Basic Average Shares,2021-03-31 00:00:00,8847600.0,ENFUSE.NS
Diluted EPS,2021-03-31 00:00:00,1.756748,ENFUSE.NS
Basic EPS,2021-03-31 00:00:00,1.756748,ENFUSE.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,15543000.0,ENFUSE.NS
Net Income Common Stockholders,2021-03-31 00:00:00,15543000.0,ENFUSE.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,0.0,ENFUSE.NS
Net Income,2021-03-31 00:00:00,15543000.0,ENFUSE.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,15543000.0,ENFUSE.NS
Net Income Continuous Operations,2021-03-31 00:00:00,15543000.0,ENFUSE.NS
Tax Provision,2021-03-31 00:00:00,5322000.0,ENFUSE.NS
Pretax Income,2021-03-31 00:00:00,20865000.0,ENFUSE.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,7000.0,ENFUSE.NS
Special Income Charges,2021-03-31 00:00:00,0.0,ENFUSE.NS
Write Off,2021-03-31 00:00:00,0.0,ENFUSE.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,-16000.0,ENFUSE.NS
Total Other Finance Cost,2021-03-31 00:00:00,16000.0,ENFUSE.NS
Interest Expense Non Operating,2021-03-31 00:00:00,0.0,ENFUSE.NS
Interest Income Non Operating,2021-03-31 00:00:00,0.0,ENFUSE.NS
Operating Income,2021-03-31 00:00:00,20874000.0,ENFUSE.NS
Operating Expense,2021-03-31 00:00:00,63814000.0,ENFUSE.NS
Other Operating Expenses,2021-03-31 00:00:00,52873000.0,ENFUSE.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,1289000.0,ENFUSE.NS
Amortization,2021-03-31 00:00:00,341000.0,ENFUSE.NS
Depreciation Income Statement,2021-03-31 00:00:00,948000.0,ENFUSE.NS
Selling General And Administration,2021-03-31 00:00:00,4119000.0,ENFUSE.NS
Selling And Marketing Expense,2021-03-31 00:00:00,510000.0,ENFUSE.NS
General And Administrative Expense,2021-03-31 00:00:00,3609000.0,ENFUSE.NS
Rent And Landing Fees,2021-03-31 00:00:00,2582000.0,ENFUSE.NS
Gross Profit,2021-03-31 00:00:00,84688000.0,ENFUSE.NS
Cost Of Revenue,2021-03-31 00:00:00,87331000.0,ENFUSE.NS
Total Revenue,2021-03-31 00:00:00,172019000.0,ENFUSE.NS
Operating Revenue,2021-03-31 00:00:00,172019000.0,ENFUSE.NS
